Pharmacoeconomic evaluation for Chinese medicine products: Progress, challenges, and suggestions
Pharmacoeconomics and Policy · 2026-06 · 2 (2) · 69-76
DOI: 10.1016/j.pharp.2026.06.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacoeconomics and Policy, 2026-06. Verfasst von Yunfeng Lai und 2 weiteren Autor:innen. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundo para o Desenvolvimento das Ciências e da Tecnologia, Guangzhou University of Chinese Medicine.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Fundo para o Desenvolvimento das Ciências e da Tecnologia
- Guangzhou University of Chinese Medicine
Zitieren
APA
Lai, Y., Yao, D., & Hu, H. (2026). Pharmacoeconomic evaluation for Chinese medicine products: Progress, challenges, and suggestions. Pharmacoeconomics and Policy, 2(2), 69-76. https://doi.org/10.1016/j.pharp.2026.06.001
Vancouver
Lai Y, Yao D, Hu H. Pharmacoeconomic evaluation for Chinese medicine products: Progress, challenges, and suggestions. Pharmacoeconomics and Policy. 2026;2(2):69-76. doi:10.1016/j.pharp.2026.06.001
BibTeX
@article{Lai2026,
author = {Lai, Yunfeng and Yao, Dongning and Hu, Hao},
title = {Pharmacoeconomic evaluation for Chinese medicine products: Progress, challenges, and suggestions},
journal = {Pharmacoeconomics and Policy},
year = {2026},
volume = {2},
number = {2},
pages = {69--76},
doi = {10.1016/j.pharp.2026.06.001}
}
EUVIMED